Correlation Between Verona Pharma and Eli Lilly

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Verona Pharma and Eli Lilly at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Verona Pharma and Eli Lilly into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Verona Pharma PLC and Eli Lilly and, you can compare the effects of market volatilities on Verona Pharma and Eli Lilly and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Verona Pharma with a short position of Eli Lilly. Check out your portfolio center. Please also check ongoing floating volatility patterns of Verona Pharma and Eli Lilly.

Diversification Opportunities for Verona Pharma and Eli Lilly

-0.76
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Verona and Eli is -0.76. Overlapping area represents the amount of risk that can be diversified away by holding Verona Pharma PLC and Eli Lilly and in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Eli Lilly and Verona Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Verona Pharma PLC are associated (or correlated) with Eli Lilly. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Eli Lilly has no effect on the direction of Verona Pharma i.e., Verona Pharma and Eli Lilly go up and down completely randomly.

Pair Corralation between Verona Pharma and Eli Lilly

Given the investment horizon of 90 days Verona Pharma PLC is expected to generate 2.15 times more return on investment than Eli Lilly. However, Verona Pharma is 2.15 times more volatile than Eli Lilly and. It trades about 0.07 of its potential returns per unit of risk. Eli Lilly and is currently generating about 0.09 per unit of risk. If you would invest  1,394  in Verona Pharma PLC on August 23, 2024 and sell it today you would earn a total of  2,392  from holding Verona Pharma PLC or generate 171.59% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Verona Pharma PLC  vs.  Eli Lilly and

 Performance 
       Timeline  
Verona Pharma PLC 

Risk-Adjusted Performance

15 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Verona Pharma PLC are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Verona Pharma sustained solid returns over the last few months and may actually be approaching a breakup point.
Eli Lilly 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Eli Lilly and has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of sluggish performance in the last few months, the Stock's essential indicators remain fairly strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Verona Pharma and Eli Lilly Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Verona Pharma and Eli Lilly

The main advantage of trading using opposite Verona Pharma and Eli Lilly positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Verona Pharma position performs unexpectedly, Eli Lilly can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eli Lilly will offset losses from the drop in Eli Lilly's long position.
The idea behind Verona Pharma PLC and Eli Lilly and pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.

Other Complementary Tools

Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Fundamental Analysis
View fundamental data based on most recent published financial statements
Commodity Directory
Find actively traded commodities issued by global exchanges
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Technical Analysis
Check basic technical indicators and analysis based on most latest market data